Dr. Vishnu Priya

Qualification               : Ph.D.

Specialization             : Pharmaceutics

E mail                           : vishnu.priya@nmims.edu

Phone                          : 022-42332000 (Extn- 2093)

Experience                 : á·ˆ  3 year (academic experience)

My research is centered on the design and development of targeted nanomedicines for the treatment of thrombotic diseases, an area that lies at the exciting intersection of drug delivery, nanotechnology, and biomedical science.

Over the past nine years—spanning all my Master’s, Ph.D and academic experience—I have worked extensively on creating innovative nanoscale drug delivery systems that enhance therapeutic precision and reduce side effects. My work involves a broad range of nanocarriers, including: Liposomes, Mesoporous silica nanoparticles, Ethosomes, Nanogels, micelles, and polymeric nanoparticles.

I have explored chemical modification of polymers, ligand-based targeting strategies, and advanced spectroscopic and analytical techniques to fine-tune the behavior of these systems in both in-vitro and in-vivo settings.

Interest areas:

• Antithrombotic nanomedicine
• Nanotechnology based drug delivery
• Novel drug delivery systems

Research

• Publications – Total number (International- 23)
• Book Chapters- 02
• Presentations- Total number (International- 02 , National-    05 )

Conferences/Workshops/Seminars attended- 10 

Academic activities

• Guided four B.Pharm. students for their final year research projects.
• Member and editor of newsletter committee
• Member of seed funding committee
• Member of gender sensitization cell

 Awards

• Awarded Teaching Assistantship during Ph.D. (2018-2023)
• Awarded AICTE fellowship during M. Pharm (2015-2017)
• Qualified three times Graduate Pharmacy Aptitude Test (GPAT), Secured AIR-170 Rank in GPAT 2015
• Awarded as Excellor in quiz contest "Pharma talent hunt 2011-2014” organized by Leaders Academy

Professional Memberships

• Registered Pharmacist (Bihar Pharmacy Council, Patna)
• Controlled release society

Recent Publications

1. Priya, V., Samridhi, Singh, N., Dash, D., & Muthu, M. S. (2023). Nattokinase encapsulated nanomedicine for targeted thrombolysis: development, improved in vivo thrombolytic effects, and ultrasound/photoacoustic imaging. Molecular Pharmaceutics (ACS), 21(1), 283-302.(Impact factor: 4.5)
2. Priya, V., Vikas, Mehata, A.K., Jain, D., Singh, S.K. and Muthu, M.S., (2022). Efficient delivery of abciximab using mesoporous silica nanoparticles: in-vitro assessment for targeted and improved antithrombotic activity. Colloids and Surfaces B: Biointerfaces 218, 112697. (Impact factor: 5.4)
3. Priya, V., Singh, S.K., Revand, R., Kumar, S., Mehata, A.K., Sushmitha, P., Mahto, S.K. and Muthu, M.S., (2022). GPIIb/IIIa Receptor targeted rutin loaded liposomes for site-specific antithrombotic effect. Molecular Pharmaceutics (ACS) 20(1), 663-679. (Impact factor: 4.5)
4. Priya, V., Viswanadh, M.K., Mehata, A.K., Jain, D., Singh, S.K. and Muthu, M.S., (2021). Targeted nanotherapeutics in the prophylaxis and treatment of thrombosis. Nanomedicine, 16(13), 1153-1176. (Impact factor: 4.7)
5. Bhanukiran, K., Priya, V., (2024). Exploring Multitarget Potential of Piper nigrum Fruit Constituents for Alzheimer's Disease: An AI-Driven Strategy. Phytomedicine, 156108 , In Press (Impact factor: 6.7)
6. Samridhi, Setia, A., Mehata, A. K., Priya, V., Pradhan, A., Prasanna, P., Mohan, S., & Muthu, M. S. (2024). Nanoparticles for thrombus diagnosis and therapy: emerging trends in thrombus-theranostics. Nanotheranostics, 8(2), 127.
7. Malik, A. K., Setia, A., Mehata, A. K., Priya, V., Nikitha Lakshmi Suseela, M., Gokul, P.,& Muthu, M. S. (2024). Green analytical chemistry: Experimental and chemometric methods for the detection of therapeutics using liquid chromatography in wastewater samples. Analytical Chemistry Letters, 1-28. . (Impact factor: 1)
8. Dhamija, P., Mehata, A.K., Setia, A., Priya, V., Malik, A.K., Bonlawar, J., Verma, N., Badgujar, P., Randhave, N. and Muthu, M.S., (2023). Nanotheranostics: molecular diagnostics and nanotherapeutic evaluation by photoacoustic/ultrasound imaging in small animals. Molecular Pharmaceutics (ACS). 20(12), 6010-6034 (Impact factor: 4.5)
9. Setia, A., Mehata, A. K., Priya, V., Pawde, D. M., Jain, D., Mahto, S. K., & Muthu, M. S. (2023). Current advances in nanotheranostics for molecular imaging and therapy of cardiovascular disorders. Molecular Pharmaceutics (ACS), 20(10), 4922-4941. (Impact factor: 4.5)
10. Suseela, M. N. L., Viswanadh, M. K., Mehata, A. K., Priya, V., Setia, V. A., Malik, A. K., Gokul, P., Selvin, J. & Muthu, M. S. (2023). Advances in solid-phase extraction techniques: role of nanosorbents for the enrichment of antibiotics for analytical quantification. Journal of Chromatography A, 463937. (Impact Factor: 3.8)
11. Vikas, Sahu, H. K., Mehata, A. K., Viswanadh, M. K., Priya, V., & Muthu, M. S. (2022), Dual-receptor-targeted nanomedicines: emerging trends and advances in lung cancer therapeutics. Nanomedicine (Lond).17(19), 1375-1395. (Impact Factor: 4.7)
12. Singh, C., Mehata, A.K., Priya, V., Malik, A.K., Setia, A., Suseela, M.N.L., Gokul, P., Singh, S.K. and Muthu, M.S., (2022). Bimetallic Au–Ag Nanoparticles: Advanced Nanotechnology for Tackling Antimicrobial Resistance. Molecules, 27(20), 7059. (Impact factor: 4.2)
13. Rout, S.K., Priya, V., Mehata, A.K. and Muthu, M.S., (2022). Abciximab coated albumin nanoparticles of rutin for improved and targeted antithrombotic effect. Journal of Drug Delivery Science and Technology, 76, 103785. (Impact factor: 4.5)
14. Rout, S.K., Priya, V., Setia, A., Mehata, A.K., Mohan, S., Albratty, M., Najmi, A., Meraya, A.M., Makeen, H.A., Tambuwala, M.M. and Muthu, M.S., (2022). Mitochondrial targeting theranostic nanomedicine and molecular biomarkers for efficient cancer diagnosis and therapy. Biomedicine & Pharmacotherapy, 153, 113451. (Impact factor: 6.9)
15. Manners, N., Priya, V., Mehata, A.K., Rawat, M., Mohan, S., Makeen, H.A., Albratty, M., Albarrati, A., Meraya, A.M. and Muthu, M.S., 2022. Theranostic nanomedicines for the treatment of cardiovascular and related diseases: current strategies and future perspectives. Pharmaceuticals, 15(4), 441. (Impact factor: 4.3)
16. Dehari, D., Mehata, A.K., Priya, V., Parbat, D., Kumar, D., Srivastava, A.K., Singh, S. and Agrawal, A.K., (2022). Luliconazole nail lacquer for the treatment of onychomycosis: formulation, characterization and in vitro and ex vivo evaluation. AAPS PharmSciTech, 23(6), 1-17. (Impact factor: 3.4)
17. Vikas, Viswanadh, M.K., Mehata, A.K., Sharma, V., Priya, V., Varshney, N., Mahto, S.K. and Muthu, M.S., (2021). Bioadhesive chitosan nanoparticles: Dual targeting and pharmacokinetic aspects for advanced lung cancer treatment. Carbohydrate Polymers, 274, 118617. (Impact factor: 10.7)
18. Mehata, A.K., Viswanadh, M.K., Priya, V., Vikas and Muthu, M.S., (2021). Harnessing immunological targets for COVID-19 immunotherapy. Future Virology, 16(9), 619-640. (Impact factor: 2.1)
19. Viswanadh, M.K., Vikas, Jha, A., Reddy Adena, S.K., Mehata, A.K., Priya, V., Neogi, K., Poddar, S., Mahto, S.K. and Muthu, M.S., (2020). Formulation and in vivo efficacy study of cetuximab decorated targeted bioadhesive nanomedicine for non-small-cell lung cancer therapy. Nanomedicine, 15(24), 2345-2367. (Impact factor: 4.7)
20. Mehata, A.K., Viswanadh, M.K., Priya, V., Vikas and Muthu, M.S., (2020). Dendritic cell-targeted theranostic nanomedicine: advanced cancer nanotechnology for diagnosis and therapy. Nanomedicine, 15(10), 947-949. (Impact factor: 4.7)
21. Narendra, Mehata, A.K., Viswanadh, M.K., Sonkar, R., Pawde, D.M., Priya, V., Singh, M., Koch, B. and S Muthu, M., (2020). Formulation and in vitro evaluation of upconversion nanoparticle-loaded liposomes for brain cancer. Therapeutic Delivery, 11(9), 557-571. (Impact factor: 3)
22. Vikas, Viswanadh, M.K., Priya, V., Mehata, A.K. and Muthu, M.S., 2020. What are the unexplored facts about nanomicelles formed from docetaxel clinical injection?. Therapeutic Delivery, 11(1), 801-803. (Impact factor: 3)
23. Mehata, A.K., Dubey, T., Bhanukiran, K., Dehari, D., Priya, V. and Muthu, M.S., (2017). Receptor targeted nanomedicine as emerging platform for brain cancer therapy. World Journal of Pharmaceutical Research 6(3), 487-497

BOOK CHAPTERS

1. Mehata, A.K., Dehari, D., Vikas, Priya, V., (2023) Drug releasing textile materials: current developments and future” S. Navneet, B. Bhupendra. "Fibre and textile engineering in drug delivery systems”, Elsevier. Woodhead Publishing, 1-38.
2. Setia, A., Mehata, A.K., Priya, V., Malik, A.K., Vikas, and Muthu, M.S., (2023) Functionalized magnetic nanosystems for diagnostic tools and devices, Deshmukh, "Synthesis and processing methods of magnetic nanosystems for diagnostic tools and devices: Design strategies and physicochemical aspects” Elsevier, 43-78.